Browse Related Topics For:

Pharmaceutical Industry The United States Food and Drug Administration

325
Prescription Drugs
174
Biosimilars
167
Generic Drugs
148
Patents
136
Pharmaceutical Patents
130
Medical Devices
94
Off-Label Promotion
91
BPCIA
91
Patent Litigation
89
Patent Infringement
88
ANDA
85
Healthcare
74
FDCA
70
Biologics
70
Hatch-Waxman
62
First Amendment
56
Popular
55
Sandoz
53
Amgen
52
Off-Label Use
51
Labeling
45
Manufacturers
44
Amarin
41
Sandoz v Amgen
40
Draft Guidance
37
HHS
37
Preemption
37
SCOTUS
35
Clinical Trials
35
FDA Approval
34
Medicare
33
Affordable Care Act
33
Free Speech
31
Misbranding
30
Advertising
30
Marketing
30
Medicaid
29
FTC
29
Life Sciences
29
Preliminary Injunctions
28
Drug Compounding
27
Pharmacies
26
21st Century Cures Initiative
26
Failure To Warn
24
CMS
24
Commercial Speech
24
Health Care Providers
23
Warning Labels
20
Biotechnology
19
Appeals
19
False Claims Act (FCA)
18
DOJ
18
Drug Safety
18
NIH
18
Product Labels
17
Enforcement Actions
16
AbbVie
16
Apotex
16
Biologics Price Competition and Innovation Act of 2009
16
Medical Research
16
Patent-in-Suit
16
Physicians
15
Commercial Marketing
15
Patent Dance
15
Safe Harbors
15
Social Media
14
aBLA
14
Caronia
14
Citizen Petitions
14
Class Action
14
Comment Period
14
New Guidance
14
Orphan Drugs
14
Patent Applications
13
Antitrust Litigation
13
Corporate Counsel
13
Hospitals
13
Johnson & Johnson
13
Reverse Payment Settlement Agreements
13
Settlement
12
Drug Pricing
12
DSCSA
12
FFDCA
12
Healthcare Reform
12
OIG
12
PHRMA
12
Proposed Regulation
12
Public Health Service Act
12
Summary Judgment
12
Teva Pharmaceuticals
11
DQSA
11
Final Guidance
11
GlaxoSmithKline
11
Legislative Agendas
11
Mylan Pharmaceuticals
11
Notice Requirements
10
Declaratory Judgments
10
Discovery
10
Enforcement
10
EU
10
FTC v Actavis
10
Hospira
10
Multidistrict Litigation
10
PLIVA v Mensing
10
Professional Conferences
10
Research and Development
10
SEC
10
Supply Chain
10
Warning Letters
9
Bayer
9
Civil Monetary Penalty
9
Final Rules
9
Health Insurance
9
Personal Jurisdiction
9
Product Exclusivity
9
Proposed Legislation
9
Reporting Requirements
9
Social Networks
9
USPTO
8
3D Printing
8
Criminal Prosecution
8
False Advertising
8
Fraud
8
Innovation
8
Medicare Part D
8
Orange Book
8
Pending Legislation
8
Pfizer
8
Public Meetings
8
Section 340B
8
Trademarks
7
Actavis Inc.
7
Adverse Events
7
Antitrust Violations
7
Cancer
7
CDC
7
Disclosure Requirements
7
Drug Approvals
7
Drug Distribution
7
HRSA
7
Janssen Pharmaceuticals
7
Merck
7
Misleading Statements
7
PHSA
7
Prior Art
7
Product Hopping
7
Public Comment
7
Qui Tam
7
REMS
7
Side Effects
7
Whistleblowers
6
Abbott Laboratories
6
Barack Obama
6
Birth Defects
6
Compliance
6
Congressional Investigations & Hearings
6
Design Defects
6
Federal Funding
6
FOIA
6
GAO
6
HIPAA
6
Inter Partes Review (IPR) Proceeding
6
Motion to Dismiss
6
Obviousness
6
Opioid
6
Otsuka Pharmaceutical
6
Product Defects
6
Public Hearing
6
Regulatory Standards
6
Securities Fraud
6
Sherman Act
6
Standing
6
Watson Pharmaceuticals
6
Websites
6
World Health Organization
5
Administrative Procedure Act
5
Allergan Inc
5
Black Box Warnings
5
Brand
5
Celebrity Endorsements
5
CHIP
5
Competition
5
Cybersecurity
5
DEA
5
Diagnostic Tests
5
Eli Lilly
5
Exclusivity
5
Expert Testimony
5
Federal Rule 12(b)(6)
5
Fifth Amendment
5
Health Information Technologies
5
Illegal Drugs
5
Infringement
5
Injunctive Relief
5
Jurisdiction
5
Learned Intermediary
5
Medicare Part B
5
Medtronic
5
Negligence
5
Novartis
5
Patent Invalidity
5
Pay-For-Delay
5
Personalized Medicine
5
Scientific Research
5
Unfair Competition
5
Unfair or Deceptive Trade Practices
5
USDA
4
21st Century Cures Act
4
Advisory Committee
4
America Invents Act
4
Anti-Competitive
4
Anti-Kickback Statute
4
Boehringer
4
Canada
4
Causation
4
Certiorari
4
Claim Construction
4
Class Certification
4
Classen Immunotherapies
4
Databases
4
Dietary Supplements
4
DNA
4
Durable Medical Equipment
4
Elan Pharmaceuticals
4
EPA
4
European Medicines Agency (EMA)
4
FDA Warning Letters
4
FDASIA
4
Federal Rules of Civil Procedure
4
Healthcare Fraud
4
Home Health Care
4
Inadequate Warning
4
Informed Consent
4
Insider Trading
4
Intellectual Property Protection
4
IRS
4
Kickbacks
4
Kim Kardashian
4
Legislative Committees
4
Licenses
4
Mergers
4
Misleading Impressions
4
Monopolization
4
New Legislation
4
No-AG Agreement
4
OMB
4
OPDP
4
Outsourcing
4
OxyContin
4
PDUFA
4
Pleading Standards
4
Pregnancy
4
Product Recalls
4
Samsung
4
Securities Litigation
4
Shareholders
4
Technology
4
UAW
3
510(k) RTA
3
Acquisitions
3
Allergan v Sandoz
3
Antitrust Provisions
3
Big Data
3
Biogen Idec
3
Biopharmaceutical
3
Burden of Proof
3
CEOs
3
CGMP
3
Chevron Deference
3
China
3
Contraceptives
3
Controlled Substances Act
3
Covered Entities
3
Data Protection
3
Daubert Standards
3
Declaratory Relief
3
Disgorgement
3
Dismissals
3
EHR
3
Employee Benefits
3
Exclusive Dealing Agreements
3
False Statements
3
FCPA
3
Federal Register
3
Financial Conduct Authority (FCA)
3
Financial Markets
3
Food Recalls
3
Foreign Manufacturers
3
Generic
3
Genzyme
3
Google
3
Healthcare Facilities
3
Innovator Liability
3
Intellectual Property Litigation
3
Internet
3
Investigational New Drug Application (IND)
3
Laboratory Developed Tests
3
Lanham Act
3
License Agreements
3
Long Term Care Facilities
3
MedPAC
3
Mental Health
3
Mutual Pharmaceuticals v Bartlett
3
On-Sale Bar
3
openFDA
3
Pain Management
3
Patent Trial and Appeal Board
3
Patent-Eligible Subject Matter
3
Patient Safety
3
Patients
3
Permanent Injunctions
3
Premarket Approval Applications
3
Prescription Drug Coverage
3
Private Right of Action
3
Public Disclosure
3
Public Health
3
Public Health Insurance Marketplace
3
Purple Book
3
Putative Class Actions
3
Regulatory Agenda
3
Regulatory Oversight
3
Risk Management
3
Rule-of-Reason Analysis
3
Sealed Records
3
Secretary of HHS
3
Securities
3
Settlement Agreements
3
SNDAs
3
Software
3
Strategic Enforcement Plan
3
Subject Matter Jurisdiction
3
Substance Abuse
3
Sunshine Act
3
Takeda Pharmaceuticals
3
Tax Credits
3
Telemedicine
3
Trade Secrets
3
Trump Administration
3
Twitter
3
Verification Requirements
3
Veterinary Products
3
Wholesale
3
Wyeth
2
ACOs
2
All Writs Act
2
American Medical Association
2
Amicus Briefs
2
AMP v Myriad
2
Animal Drugs
2
Animal Testing
2
Antibiotics
2
Antitrust Injuries
2
Article III
2
AstraZeneca
2
Attorney Generals
2
Attorney-Client Privilege
2
Audits
2
Bifurcation
2
Bristol-Myers Squibb
2
Celltrion
2
Center for Drug Evaluation and Research (CDER)
2
Cephalon
2
Chemicals
2
Clear and Convincing Evidence
2
Clinical Laboratories
2
Combination Products
2
Confidential Information
2
Conflicts of Interest
2
Controlled Substances
2
Conversion
2
Corporate Integrity Agreement
2
Cosmetics
2
Counterclaims
2
Counterfeit Drugs
2
Daiichi Sankyo
2
DaimlerChrysler v Bauman
2
Data Breach
2
Disclaimers
2
Diversity Jurisdiction
2
DMEPOS
2
Drug & Alcohol Abuse
2
Due Process
2
Duty to Deal
2
Endo Pharmaceuticals
2
Ethics
2
Evidence
2
Exemptions
2
Expert Witness
2
Failure To Disclose
2
FD&C Act
2
Federal Health Care Programs (FHCP)
2
Federal Question Jurisdiction
2
Financial Sector
2
First Impression
2
First-to-File
2
Food and Drug Administration Amendments Act (FDAAA)
2
Fraudulent Joinder
2
FSMA
2
GDUFA
2
General Jurisdiction
2
Genetic Testing
2
Gilead Sciences
2
Government Investigations
2
GPOs
2
Guidance Update
2
Hackers
2
HCEI
2
Health Insurance Exchanges
2
Health Safety
2
HITECH
2
HIV
2
Imports
2
Induced Infringement
2
Injunctions
2
Inpatient Prospective Payment System (IPPS)
2
Inspections
2
Insurance Industry
2
Interchangeability
2
Internal Controls
2
Internet Marketing
2
Interstate Commerce
2
Inventors
2
Investors
2
IP License
2
IRB
2
Licensing Rules
2
Manufacturing Defects
2
Marijuana
2
Medicaid Expansion
2
Medical Malpractice
2
Medical Reimbursement
2
Medicare Advantage
2
Mensing
2
Misrepresentation
2
Mobile Apps
2
Mootness
2
National Cancer Moonshot
2
Native American Issues
2
Nike
2
Notice Provisions
2
Omnibus Guidance
2
Omnicare
2
Omnicare v Laborers District Council
2
Online Advertisements
2
Outsourcing Facilities
2
Over-the-Counter Sales
2
Patient Privacy Rights
2
Pay-Per-Click
2
Petition for Writ of Certiorari
2
POM Wonderful
2
Post-Grant Review
2
Presidential Elections
2
PSLRA
2
Qualified Small Employer Health Reimbursement Plan (QSEHRAs)
2
Quality Control Plan
2
RanBaxy
2
Registration Requirement
2
Reimbursements
2
Relators
2
Reverse Payments
2
Right to Try
2
Ripeness
2
Risk Assessment
2
Rulemaking Process
2
Safety Precautions
2
Sanctions
2
Sanofi
2
Schering-Plough
2
Search Engines
2
Section 503
2
Securities Exchange Act
2
Securities Violations
2
Skilled Nursing Facility
2
Spectrum
2
Stark Law
2
Startups
2
Statute of Limitations
2
Stem cells
2
Strict Liability
2
Subsidies
2
Tax Deductions
2
Transfer of Venue
2
TRO
2
Two-Midnight Rule
2
Twombly/Iqbal Pleading Standard
2
UK
2
User-Generated Content
2
Venture Capital
2
Warner Chilcott
2
Written Descriptions
2
Wrongful Death
2
Young Lawyers
1
35 U.S.C. § 271(e)(1)
1
Acceleration
1
Accounting Controls
1
Actos
1
Actual Injuries
1
Addiction Equity Act
1
Additive Manufacturing
1
Administrative Proceedings
1
Admissible Evidence
1
Advance Notice
1
Advisory Opinions
1
Aerospace
1
AHRQ
1
AIDS
1
AIG
1
ALJ
1
All Natural
1
Alzheimer's
1
Amazon
1
Amended Complaints
1
Amended Regulation
1
Amgen Inc. v Connecticut Retirement Plans
1
Amgen v Apotex
1
Animal Food
1
Animal Health
1
Anti-Monopoly
1
Antimicrobials
1
Antitrust Conspiracies
1
App Developers
1
Applicable Manufacturers
1
Applications
1
Appointments Clause
1
Appropriate Equitable Relief
1
Arbitration
1
Article II
1
Asbestos
1
Asbestos Litigation
1
Assignments
1
Attestation Deadlines
1
Automobile Recall
1
Automotive Industry
1
Bank of New York (BNY) Mellon
1
Banking Sector
1
Barclays
1
Bayh-Dole Act
1
Benefit Plan Reimbursements
1
Best Buy
1
Best Management Practices
1
Best Practices
1
Billing
1
Bilski
1
Biometric Information
1
Bipolar Disorder
1
Birth Control Pill
1
Boston Scientific
1
BPCI
1
Brand Name Prescription Drugs
1
Breakthrough Therapy Designation
1
Business Associates
1
Business Development
1
C&DIs
1
CA Supreme Court
1
CAFC
1
Canadian Intellectual Property Office
1
Cartwright Act
1
Carve Out Provisions
1
Caterpillar
1
CCIIO
1
CERCLA
1
CFPB
1
Chief Compliance Officers
1
Childrens' Motrin
1
Chilling Effect
1
Chip and PIN
1
Cipro
1
Citizen Suits
1
Claim Preclusion
1
Clean Air Act
1
Clean Water Act
1
clear
1
Clearance
1
Climate Action Plan
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CMMI
1
Co-payments
1
COBRA
1
Coca Cola
1
Commerce Clause
1
Commitment Letter
1
Common Law Claims
1
Community Health Systems
1
Compensation & Benefits
1
Compensatory Awards
1
Compensatory Damages
1
Competitive Bidding
1
Complete Genomics
1
Comptroller of the Treasury v Wynne
1
Confidential Documents
1
Conflicting Proposals
1
Congressional Review Act
1
Consent Decrees
1
Constitutional Challenges
1
Consumer Fraud
1
Consumer Product Safety Commission (CPSC)
1
Consumer Protection Act
1
Consumers Legal Remedies Act
1
Contamination
1
Contests & Promotions
1
Continuing Medical Education
1
Contraceptive Coverage Mandate
1
Contract Drafting
1
Contributory Infringement
1
Copyright
1
Corporate Misconduct
1
Corporate Taxes
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Recipients
1
CPUC
1
CREATE Act
1
Credibility
1
Cross-Border Transactions
1
Crowdfunding
1
Cruel & Unusual Punishment
1
Cuozzo Speed Technologies v Lee
1
Customs and Border Protection
1
CVM
1
Cyber Attacks
1
Cyber Threats
1
DaimlerAG
1
Data Controller
1
Data Integrity
1
Data Mining
1
Data Security
1
De Minimis Claims
1
De Novo Standard of Review
1
Debit and Credit Card Transactions
1
Deceptive Intent
1
Defect
1
Defense Strategies
1
Delaware General Corporation Law
1
Delays
1
Department of Transportation (DOT)
1
Department of Veterans Affairs
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Method
1
Direct Infringement
1
Direct Purchasers
1
Direct to Consumer Sales
1
Dirks v SEC
1
Disability Discrimination
1
Disclosure
1
Discounts
1
Discussion Draft
1
Disruptive Technology
1
Distributors
1
Document Retention Policies
1
Dodd-Frank
1
DOL
1
Donald Trump
1
Double Jeopardy
1
Drug Testing
1
Drug Treatment
1
DSHEA
1
Duty to Warn
1
E-Filing
1
EAR
1
Earn-Outs
1
EEOC
1
Eighth Amendment
1
Electronic Communications
1
Electronic Filing
1
Electronic Health Record Incentives
1
Electronic Records
1
Electronically Stored Information
1
Eleventh Amendment
1
Email
1
Embargo
1
Emerging Markets
1
Employer Group Health Plans
1
Employer Mandates
1
En Banc Review
1
Environmental Policies
1
ERISA
1
Ernst & Young
1
EU-US Privacy Shield
1
European Food Safety Authority (EFSA)
1
Events
1
Evidence Suppression
1
Ex Post Facto Clause
1
Excessive Pricing
1
Excise Tax
1
Executive Orders
1
Expedited FDA Approval
1
Export Controls
1
Exports
1
Failure To State A Claim
1
Fair Notice
1
False Evidence
1
False Press Release
1
Falsified Documents
1
Fast Track Process
1
FBI
1
FCC
1
Federal Budget
1
Federal Rule 12(b)(1)
1
Federal v State Law Application
1
FedEx
1
Fee-for-Service
1
Fee-Shifting
1
Fiduciary Duty
1
Fiduciary Rule
1
Financial Institutions
1
Flame Retardant
1
Flexible Spending Accounts
1
FMCSA
1
Food Labeling
1
Food Poisoning
1
Foreign Corporations
1
Foreign Earned Income
1
Foreign Tax
1
Foreseeability
1
Form 10-K
1
Form 8-K
1
Forum Shopping
1
Fraud-on-the-Market
1
FRCP 26
1
FSMB
1
FTC Act
1
Funding
1
Genentech
1
General Electric
1
General Services Administration (GSA)
1
General Wellness Devices
1
Genetic Materials
1
Goldman Sachs
1
Good Cause
1
Good Clinical Practices
1
Goodyear
1
Grable Factors
1
Grocery Stores
1
gTLD
1
Guilty Pleas
1
Halliburton v Erica P. John Fund
1
Hazardous Substances
1
Hazardous Waste
1
HCPCS
1
Health Canada
1
Health Care Violations
1
Health IT
1
Health Savings Accounts
1
Healthcare Costs
1
HELP
1
Hewlett-Packard
1
Hoffman LaRoche
1
Home Depot
1
Homeopathic Remedies
1
Honeybees
1
Hospice
1
HRA
1
Human Genome Project
1
Human Rights
1
ICD-10
1
Illegal Tipping
1
Implied Certification
1
In-Person Exam
1
Incentives
1
Income Taxes
1
Indictments
1
Indirect Infringement
1
Individual Mandate
1
Infectious Diseases
1
Information Reports
1
Information Sharing
1
Initial Public Offerings
1
Inpatient Rehab Facilities
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Interest Rate Adjustments
1
Interest Rates
1
InterMune
1
International Arbitration
1
International Harmonization
1
Internet Retailers
1
INTERPOL
1
Interpretive Rule
1
Investigational Device Exemptions
1
Investigational New Drug procedures (IND)
1
Investment
1
Investment Adviser
1
Investment Advisers Act of 1940
1
Investment Trust Companies
1
IRF Claim Processing
1
JAMA
1
Janus Capital Group
1
Joinder
1
Joint Venture
1
Journalists
1
Judicial Review
1
Jury Awards
1
Jury Trial
1
Justiciable Controversy
1
King v Burwell
1
KPMG
1
LabMD
1
Law Enforcement
1
Leave to Amend
1
Legal History
1
Legal Perspectives
1
Lipitor
1
Litigation Hold
1
Litigation Privilege
1
Lobbyists
1
Local Ordinance
1
Loss Causation
1
MA Supreme Court
1
Managed Care Contracts
1
Manufacturing Facilities
1
Marijuana Cultivation
1
Marijuana Related Businesses
1
Market Manipulation
1
Market Research
1
MasterCard
1
Material Misstatements
1
MCOs
1
Medical Foods
1
Medical Liability
1
Medical Supplies
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Medicare Modernization Act
1
Medicare Prescription Drug Improvement and Modernization Act (MMA)
1
Memorandum of Understanding
1
Mental Health Initiatives
1
Mental Health Parity Rule
1
Merrill Lynch v Manning
1
Methane
1
Method Claims
1
Minor Children
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Remand
1
Motion To Stay
1
Motor Carriers
1
NAD
1
NAFTA
1
Nanomedicine
1
Nanotechnology
1
Natural Products
1
Negligence Per Se
1
Negligent Design
1
New Regulations
1
New Trial
1
Nexus
1
NJ Supreme Court
1
Non-Practicing Entities
1
Non-Public Information
1
Notice of Appeal
1
Notifications
1
NPRM
1
Numerosity
1
Nursing Homes
1
Obama Administration
1
OCR
1
OECD
1
OEHHA
1
OFAC
1
Office of Scientific Investigations (OSI)
1
OFVM
1
Oil & Gas
1
Omissions
1
ONC
1
Online Platforms
1
Online Reviews
1
Open Enrollment
1
OPPS
1
Opt-Outs
1
Out-of-State Companies
1
Out-of-State Judgments
1
Overpayment
1
Par Pharmaceutical
1
Parallel Claims
1
Partnerships
1
PATENT Act
1
Patent Cooperation Treaty
1
Patent Exhaustion
1
Patent Expiration
1
Patent Filings
1
Patent Portfolios
1
Patent Reform
1
Patent Term Extensions
1
Patent-Misuse
1
Patient Assistance Programs
1
Patient Prospective Payment System
1
Patient-Specific
1
Pay or Play
1
Pay Ratio
1
Pay Ratio Tax
1
Payment Records
1
Payroll Taxes
1
PCORI
1
Pediatrics
1
Penalties
1
Pension Funds
1
Pensions
1
Personal Benefit
1
Personal Care Products
1
Personal Liability
1
Personally Identifiable Information
1
Pesticides
1
Pharmaceutical Distribution
1
Pharmacist
1
PHH Corp. v CFPB
1
Planned Parenthood
1
Podcasts
1
POM Wonderful v Coca Cola
1
Posting Requirements
1
Pradaxa
1
Precision Medicine Initiative (PMI)
1
Price Gouging
1
Price Transparency
1
Primary Jurisdiction Doctrine
1
Prior User
1
Prioritized Examination
1
Prison
1
Privacy Laws
1
Privacy Policy
1
Privately Held Corporations
1
Privilege Logs
1
Product Enhancements
1
Professional Liability
1
Professional Misconduct
1
Profits
1
Prometheus
1
Proposed Amendments
1
Proposed Rules
1
Protective Orders
1
Psychiatric Hospitals
1
PTAC
1
Public Access Laws
1
Public Notice
1
Public Performance Rights
1
Public Safety
1
Publicly-Traded Companies
1
RCRA
1
Rebates
1
Recordkeeping Requirements
1
Reed v Town of Gilbert
1
Registration
1
Regulation S-K
1
Regulatory Agencies
1
Regulatory Reform
1
Release of Information
1
Remand
1
Removal For-Cause
1
Reorganizations
1
Repeal
1
Required Documentation
1
Res Ipsa Loquitur
1
Research Funding
1
RESPA
1
Restitution
1
Restraining Orders
1
Retailers
1
Retaliation
1
Reversal
1
Right of Reproduction
1
Risk Mitigation
1
Roxane Laboratories
1
Rule 10b-5
1
Rule 23
1
Rule 26
1
Safety Standards
1
Samsung Bioepis
1
Sanofi-Aventis
1
SC Supreme Court
1
Scienter
1
Scientific Evidence
1
Scope of Discovery Requests
1
SDN List
1
Section 10(b)
1
Section 11
1
Securities Act of 1933
1
Senate Judiciary Committee
1
Sham Litigation Exception
1
Shareholder Litigation
1
Short Selling
1
SmithKline Beecham
1
Social Security Act
1
Software Developers
1
Solicitor General
1
Sovereign Immunity
1
Sovereign Wealth Funds
1
Special 301
1
Specialty Healthcare
1
Specific Jurisdiction
1
Split of Authority
1
Sponsors
1
SPVs
1
Standard of Review
1
State Budgets